Business | Latest & Breaking News on Business | Photos, Videos, Breaking Stories and Articles on Business

TCS biggest wealth creator in 2012-17, Ajanta Pharma the fastest: Wealth Creation Study

Ajanta Pharma retains the tag of fastest wealth creator for the third time in a row and Asian Paints is the most consistent wealth creator, said the wealth creation study

Expect Rs 280-285 crore of topline in Sorbitol segment: Gulshan Polyols

In an interview to CNBC-TV18, Rajesh Agrawal, CFO of Gulshan Polyols spoke about the latest happenings in the company and his outlook going ahead.

GSK says its eyeing more collaborations for expansion

Patrick Vallance, President - R&D, GlaxoSmithKline said the company is looking forward to more collaborations and is looking at a number of options to move ahead with its expansion plans.

Govt needs to be a strong enabler in pharma sector: Experts

Shereen Bhan speaks with top bosses from the pharma sector along with KT Rama Rao, Minister of IT, Telangana at Bioasia 2017 to discuss way forward for pharma sector in making India healthier.

Expect drug pricing pressure to continue in next few years: GSK

The US market is seeing a shift in market dynamics and several factors lead to drug product pricing and there will be further pricing pressure over the next few years, said GSK Global Chief Executive Andrew Witty.

Looking to launch 6-7 products over next 2-3 yrs: GSK Pharma

Andrew Aristidou, CFO and ED Finance, GSK Pharma, speaks about the company‘s new launches and why GSK Pharma is in no rush to delist in India.

Sun Pharma to buy GSK's opiates business in Australia

The transaction is expected to close by August 2015.

Looking at investing Rs 900 cr in greenfield facility: GSK

HB Joshipura, Managing Director of Glaxosmithkline, said parent company GSK Plc has no plans to delist it from Indian bourses.

DRL-GSK generic formulations deal under review: PharmAsia

The DRL-GSK deal was to sell branded generic formulations in emerging markets and was entered into in 2009.

India attractive, will stay here for many more years: GSK

India is a huge investment and is one of the most strategic countries within the emerging markets, Asia Pacific and GSK will continue to build this footprint in Indian markets, says Rogerio Ribeiro.

Post stake buy, GSK may eye acquisition

After the UK parent of GlaxoSmithKline Pharmaceutical announced an open offer to increase its stake from 50.3 percent to 75 percent at a cost of Rs 6,400 crore, CNBC-TV18 spoke with an industry veteran, Former Pfizer India MD Kewal Handa to get his views.

See long-term potential in Indian market: GSK Plc

CNBC-TV18 spoke with David Redfern, Chief Strategy Officer, GlaxoSmithKline plc, to discuss the open offer, the subsidiary‘s current state of the business and its plans.

GSK's malaria vaccine not for profit pricing says CEO Witty

Malaria vaccine is a good example of the company's broad commitment to innovate and improve access to medicine and healthcare for people. It is not just a programme or a PR campaign, said GSK CEO, Andrew Witty.

See growth in India biz despite policy issues: Glaxo CEO

The GlaxoSmithKline global board is meeting in India for the very first time and Andrew Witty, CEO of the company continues to be positive about India. He expects Glaxo to rake in a turnover of a billion pounds this year.

Brought GSK board to see India's potential: CEO Witty

GlaxoSmithKline CEO Andrew Witty believes its Indian business will grow despite challenges in the Indian pharma sector

Vaccines push more for social cause than money-making: GSK

GSK India's managing director, Hasit Joshipura, spoke to CNBC-TV18's Archana Shukla about the company's growth drivers and plans.

Will look at Paras Healthcare if available in market: Emami

FMCG major Emami Ltd's Harsh Agarwal said that they were open to smaller, mid-size and even large size acquisitions. "As of now we are in talks to buy the personal care business of Paras Healthcare as an opportunity to acquire if it is available in the market," he said.